Dabur India is expected to report moderate but resilient revenue growth in the third quarter, supported by gradual improvement in rural demand, price stability and steady performance in its core health and personal care segments. While inflationary pressures and uneven urban consumption continue to pose challenges, analysts anticipate that Dabur’s diversified portfolio and strong distribution network will help sustain topline momentum. Margin performance is also likely to benefit from easing input costs, even as competitive intensity remains high.